Robert Burns
Stock Analyst at HC Wainwright & Co.
(0.89)
# 3,565
Out of 4,814 analysts
491
Total ratings
22.69%
Success rate
-23.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Reiterates: Buy | $13 | $1.31 | +896.17% | 12 | Apr 14, 2025 | |
| PRLD Prelude Therapeutics | Reiterates: Buy | $5 | $0.84 | +492.98% | 15 | Apr 8, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $45 → $44 | $12.13 | +262.89% | 3 | Apr 7, 2025 | |
| HURA TuHURA Biosciences | Maintains: Buy | $13 → $12 | $4.13 | +190.56% | 2 | Apr 3, 2025 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $36 | $9.32 | +286.27% | 15 | Apr 2, 2025 | |
| ELTX Elicio Therapeutics | Reiterates: Buy | $10 | $4.76 | +110.08% | 7 | Apr 2, 2025 | |
| BNTX BioNTech SE | Maintains: Buy | $150 → $145 | $98.76 | +46.82% | 38 | Apr 1, 2025 | |
| ADCT ADC Therapeutics | Reiterates: Buy | $8 | $1.23 | +553.06% | 21 | Mar 31, 2025 | |
| CATX Perspective Therapeutics | Reiterates: Buy | $10 | $1.92 | +422.19% | 3 | Mar 31, 2025 | |
| EXEL Exelixis | Reiterates: Buy | $40 | $36.06 | +10.93% | 7 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.27 | +57.48% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $12 | $4.69 | +155.86% | 20 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $39 | $16.59 | +135.08% | 3 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.00 | +400.00% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.45 | +451.72% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.74 | +1,112.45% | 13 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $12 | $1.44 | +733.33% | 13 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $2.80 | +1,114.29% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $13 | $11.54 | +12.65% | 20 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.02 | +395.05% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.21 | +313.22% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.70 | +493.69% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $39 | $18.15 | +114.88% | 8 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $36.75 | +98.64% | 19 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $17 | $2.85 | +496.49% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $4.77 | +340.71% | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $74 | $37.89 | +95.30% | 31 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $7.96 | +176.38% | 16 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.62 | +332.10% | 7 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.65 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $6.16 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $4.34 | +222.58% | 10 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.24 | +790.69% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.89 | +153.09% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $5.95 | +3,261.34% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $0.46 | +4,247.83% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.84 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.20 | +6,718.18% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.12 | +1,864.29% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.12 | +525.00% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $0.65 | +1,584.53% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $0.87 | +25,762.07% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.90 | +541.85% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.43 | +809.09% | 1 | Jan 7, 2021 |
Tango Therapeutics
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $1.31
Upside: +896.17%
Prelude Therapeutics
Apr 8, 2025
Reiterates: Buy
Price Target: $5
Current: $0.84
Upside: +492.98%
Bicara Therapeutics
Apr 7, 2025
Maintains: Buy
Price Target: $45 → $44
Current: $12.13
Upside: +262.89%
TuHURA Biosciences
Apr 3, 2025
Maintains: Buy
Price Target: $13 → $12
Current: $4.13
Upside: +190.56%
Nurix Therapeutics
Apr 2, 2025
Reiterates: Buy
Price Target: $36
Current: $9.32
Upside: +286.27%
Elicio Therapeutics
Apr 2, 2025
Reiterates: Buy
Price Target: $10
Current: $4.76
Upside: +110.08%
BioNTech SE
Apr 1, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $98.76
Upside: +46.82%
ADC Therapeutics
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $1.23
Upside: +553.06%
Perspective Therapeutics
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $1.92
Upside: +422.19%
Exelixis
Mar 27, 2025
Reiterates: Buy
Price Target: $40
Current: $36.06
Upside: +10.93%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.27
Upside: +57.48%
Mar 21, 2025
Maintains: Buy
Price Target: $22 → $12
Current: $4.69
Upside: +155.86%
Mar 21, 2025
Maintains: Buy
Price Target: $37 → $39
Current: $16.59
Upside: +135.08%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.00
Upside: +400.00%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.45
Upside: +451.72%
Mar 19, 2025
Reiterates: Buy
Price Target: $9
Current: $0.74
Upside: +1,112.45%
Mar 18, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $1.44
Upside: +733.33%
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $2.80
Upside: +1,114.29%
Mar 10, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $11.54
Upside: +12.65%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.02
Upside: +395.05%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.21
Upside: +313.22%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $2.70
Upside: +493.69%
Mar 7, 2025
Reiterates: Buy
Price Target: $39
Current: $18.15
Upside: +114.88%
Mar 3, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $36.75
Upside: +98.64%
Feb 28, 2025
Maintains: Buy
Price Target: $13 → $17
Current: $2.85
Upside: +496.49%
Feb 26, 2025
Reiterates: Buy
Price Target: $21
Current: $4.77
Upside: +340.71%
Feb 24, 2025
Reiterates: Buy
Price Target: $74
Current: $37.89
Upside: +95.30%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $7.96
Upside: +176.38%
Feb 10, 2025
Reiterates: Buy
Price Target: $7
Current: $1.62
Upside: +332.10%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.65
Upside: -
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $6.16
Upside: -
Jan 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $4.34
Upside: +222.58%
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.24
Upside: +790.69%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.89
Upside: +153.09%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $5.95
Upside: +3,261.34%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $0.46
Upside: +4,247.83%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.84
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.20
Upside: +6,718.18%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.12
Upside: +1,864.29%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.12
Upside: +525.00%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $0.65
Upside: +1,584.53%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $0.87
Upside: +25,762.07%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.90
Upside: +541.85%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.43
Upside: +809.09%